Autologous cell transplant as a treatment for stable segmental vitiligo: a systematic review.
Journal
International journal of dermatology
ISSN: 1365-4632
Titre abrégé: Int J Dermatol
Pays: England
ID NLM: 0243704
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
revised:
18
08
2023
received:
20
06
2023
accepted:
30
08
2023
medline:
23
10
2023
pubmed:
16
9
2023
entrez:
16
9
2023
Statut:
ppublish
Résumé
This systematic review provides a comprehensive analysis of the efficacy of autologous cell transplant as a therapeutic approach for stable segmental vitiligo. Vitiligo poses significant challenges for healthcare professionals in terms of treatment selection. Autologous cell transplant has emerged as a promising modality for managing vitiligo, with cultured and noncultured transplants being considered when determining the patient's treatment approach. There is little knowledge and literature on the subject, so we analyze the different studies. Using online medical literature databases and the PRISMA guidelines, six out of 60 articles met the acceptance criteria to be analyzed, emphasizing the lack of current literature on this subject. Autologous cell transplant achieves excellent pigmentation rates for many body parts. We found that cultivated cells had better results than noncultivated ones. Both types of treatments could pigment 80% or more where needed. This review highlights the importance of autologous cell transplant as a new and reliable tool for the treatment of stable segmental vitiligo, cultured transplants being the most effective. By employing autologous cell transplant, the repigmentation rate is notably high and consistently achievable. Although its cost and logistical complexities hinder the current accessibility to this therapy, efforts are being made to enhance its availability, and its scope is expected to expand further. More studies are needed to understand this therapy method in other kinds of vitiligo.
Types de publication
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1324-1331Informations de copyright
© 2023 the International Society of Dermatology.
Références
Rodríguez-Cerdeira C, Arenas Guzmán R, Rodríguez-Cerdeira C. El vitíligo, una enfermedad estigmática: un recorrido a través de su historia Vitiligo, a stigmatized disease: a journey throughout its history Historia de la Dermatología. Med Cutan Iber Lat Am. 2011;39(6):278-282. Available from: https://www.medigraphic.com/pdfs/cutanea/mc-2011/mc116i.pdf
Cristina A, Trémul L, Pilar M, Salas S. Vitíligo: principales opciones terapéuticas Vitiligo: main therapeutic options [Internet]. Available from: https://www.medigraphic.com/pdfs/cutanea/mc-2006/mc062i.pdf
Chen YF, Yang PY, Hu DN, Kuo FS, Hung CS, Hung CM. Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases. J Am Acad Dermatol. 2004 [cited 2023 Apr 14];51(1):68-74. Available from: https://www.jaad.org/article/S0190-9622(04)00236-1/fulltext
El-Zawahry B, Zaki N, Bassiouny D, Sobhi R, Zaghloul A, Khorshied M, et al. Autologous melanocyte-keratinocyte suspension in the treatment of vitiligo. J Eur Acad Dermatol Venereol. 2010 [cited 2023 April 12];25(2):215-220. Available from: https://pubmed.ncbi.nlm.nih.gov/20569286/
Ramos MG, Ramos DG, Gontijo G, Ramos CG, Rocha TN, Rocha RH. Non-cultured melanocyte/keratinocyte transplantation for the treatment of stable vitiligo on the face: report of two cases. Anais Brasileiros de Dermatologia. 2013 [cited 2023 Apr 14];88(5):811-813. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798362/
Zhang D, Wei X, Hong W, Fu L, Qian G, Xu A. A retrospective study of long term follow-up of 2283 vitiligo patients treated by autologous, non-cultured melanocyte-keratinocyte transplantation. Aging. 2021 [cited 2023 April 12];13(4):5415-5425. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950304/
Ramos MG, Ramos DG, Ramos CG. Evaluation of treatment response to autologous transplantation of noncultured melanocyte/keratinocyte cell suspension in patients with stable vitiligo. Anais Brasileiros de Dermatologia. 2017 [cited 2023 Apr 14];92(3):312-318. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514568/#fn1
Hong W, Hu D, Qian G, McCormick S, Xu A. Treatment of vitiligo in children and adolescents by autologous cultured pure melanocytes transplantation with comparison of efficacy to results in adults. J Eur Acad Dermatol Venereol. 2011 [cited 2023 April 12];25(5):538-543. Available from: https://pubmed.ncbi.nlm.nih.gov/20673303/
van Geel N, Ongenae K, De Mil M, Naeyaert JM. Modified technique of autologous noncultured epidermal cell transplantation for repigmenting vitiligo: a pilot study. Dermatol Surg. 2001 [cited 2023 April 14];27(10):873-876. Available from: https://pubmed.ncbi.nlm.nih.gov/11722524/
Goh BK, Chua XM, Chong KL, De Mil M, van Geel NAC. Simplified cellular grafting for treatment of vitiligo and piebaldism. Dermatol Surg. 2010 [cited 2023 Apr 14];36(2):203-207. Available from: https://pubmed.ncbi.nlm.nih.gov/20039922/
Tegta GR, Parsad D, Majumdar S, Kumar B. Efficacy of autologous transplantation of noncultured epidermal suspension in two different dilutions in the treatment of vitiligo. International Journal of Dermatology [Internet]. 2006 [cited 2023 April 14];45(2):106-110. Available from: https://pubmed.ncbi.nlm.nih.gov/16445497/
Guerra L, Capurro S, Melchi F, Primavera G, Bondanza S, Cancedda R, et al. Treatment of “stable” vitiligo by timedsurgery and transplantation of cultured epidermal autografts. Arch Dermatol. 2000 [cited 2023 Apr 14];136(11):1380-1389. Available from: https://pubmed.ncbi.nlm.nih.gov/11074702/
Bao H, Hong W, Fu L, Wei X, Qian G, Xu A. Blister roof grafting, cultured melanocytes transplantation and non-cultured epidermal cell suspension transplantation in treating stable vitiligo: a mutual self-control study. J Dermatol Treat. 2015 [cited 2023 April 14];26(6):571-574. Available from: https://pubmed.ncbi.nlm.nih.gov/26247842/
Mulekar SV. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation. Arch Dermatol. 2004 [cited 2023 Apr 14];140(10):1211-1215. Available from: https://jamanetwork.com/journals/jamadermatology/fullarticle/480828
Mulekar SV. Melanocyte-keratinocyte cell transplantation for stable vitiligo. Int J Dermatol. 2023;42(2):132-136. https://doi.org/10.1046/j.1365-4362.2003.01628.x
van Geel N, Ongenae K, De Mil M, Vander Haeghen Y, Vervaet C, Naeyaert JM. Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo. Arch Dermatol. 2004 [cited 2023 Apr 14];140(10):1203-1208. Available from: https://pubmed.ncbi.nlm.nih.gov/15492182/
Li X, Hong W, Xu AE. Two cases of focal scrotal vitiligo successfully treated by autologous cultured melanocyte transplantation. Dermatol Ther. 2014 [cited 2023 Apr 14];4(1):141-144. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065275/
Jan NA, Masood S. Vitiligo [Updated 2023]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559149/
Ezzedine K, Eleftheriadou V, Jones H, Bibeau K, Kuo F, Sturm D, et al. Psychosocial effects of vitiligo: a systematic literature review. Am J Clin Dermatol. 2021 [cited 2023 Jun 13];22(6):757-774. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566637/
Issa. Melanocyte transplantation for the treatment of vitiligo: effects of different surgical techniques. Eur J Dermatol. 2013 [cited 2023 April 14];13(1):34-39. Available from: https://pubmed.ncbi.nlm.nih.gov/12609779/